AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd is an integrated global pharmaceutical company headquartered in Hyderabad, India. Since 1986, the company has developed, manufactured, and commercialized a wide range of generic pharmaceuticals, branded specialty pharmaceuticals, and active pharmaceutical ingredients globally, operating in over 150 countries. With 25 manufacturing and packaging facilities approved by leading regulatory agencies including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, the company's robust product portfolio spans across 7 major therapeutic/product areas including CNS, Antiretroviral, CVS, Antibiotics, Gastroenterological, Anti-Diabetics, and Anti-Allergic, supported by a strong R&D setup. Aurobindo Pharma Ltd operates in the Biotechnology and Pharmaceutical industries, committed to promoting a healthier life. The company has not disclosed its last investment or the investors involved. The expansive global reach, diverse product portfolio, and adherence to international regulatory standards position Aurobindo Pharma Ltd as a major player in the pharmaceutical industry.